Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 8/20 | 0.33 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 5/20 | 0.32 |
| ▸ | CES2 | O00748 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10442030 | 0.98 | TSHR (0.50) | ALDH1A1TSHRTP53FAAHOXER1 | |
| SCHEMBL10442274 | 0.98 | TSHR (0.50) | ALDH1A1TSHRTP53FAAHOXER1 | |
| SCHEMBL8756524 | 0.98 | TSHR (0.50) | ALDH1A1TSHRTP53FAAHOXER1 | |
| SCHEMBL10442132 | 0.98 | TSHR (0.50) | ALDH1A1TSHRTP53FAAHOXER1 | |
| SCHEMBL10442040 | 0.98 | TSHR (0.50) | ALDH1A1TSHRTP53FAAHOXER1 | |
| SCHEMBL10442037 | 0.98 | TSHR (0.50) | ALDH1A1TSHRTP53FAAHOXER1 | |
| SCHEMBL10441949 | 0.98 | TSHR (0.50) | ALDH1A1TSHRTP53FAAHOXER1 | |
| SCHEMBL3971918 | 0.92 | ALDH1A1 (0.46) | ALDH1A1TSHRTP53FAAHOXER1 | |
| SCHEMBL330245 | 0.81 | — | — | |
| SCHEMBL28319606 | 0.81 | ALDH1A1 (0.43) | ALDH1A1TSHRTP53FAAHCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220411421-A1 | 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOF | CHOU, YU-CHENG (TW) | 2022-12-29 | — | — | US | disclosed |
| US-20220411421-A1 | 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOF | CHOU, YU-CHENG (TW) | 2022-12-29 | — | — | US | disclosed |
| EP-4051270-A1 | 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOF | Prime Reach Trading Limited (WS) | 2022-09-07 | — | — | EP | disclosed |
| CN-114599360-A | 4-amino-imidazoquinoline compounds and uses thereof | 骏达贸易有限公司 | 2022-06-07 | — | — | CN | disclosed |
| WO-2021086689-A1 | 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOF | PRIME REACH TRADING LIMITED (WS) | 2021-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411421-A1 | 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOF | TLR7, TLR8, TLR6 | ALDH1A1 2539/4885TSHR 3172/4885TP53 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.